Cytiva will donate a part of its October sales to the Breast Cancer Research Foundation.
Every year, Cytiva joins the global fight against breast cancer through Think Pink, a campaign dedicated to supporting the Breast Cancer Research Foundation (BCRF). For its fourth edition in 2020, Think Pink aims to fund 3,300 hours of breast cancer research, 900 more compared to the previous year.
Throughout October, Cytiva will donate $1 to BCRF for every purchase of Mab-Select chromatography resins, Whatman filter papers, Sera-Mag Select reagents and Amersham nitrocellulose membranes. These products are critical in accelerating cancer research and drug development programs.
Emmanuel Abate, Vice President and Head of Genomics and Cellular Research, Cytiva, says: “The most common form of cancer in women, breast cancer can have an impact on all of us. People affected by it can be our family members, friends or colleagues. Even while coping with the COVID-19 pandemic, cancer doesn’t slow down and no one can beat this disease alone. We proudly continue to make diagnostic kits, consumables, and instruments used to enable cancer research, and are excited to once again devote time, energy and donations to the important work done by BCRF.”
Myra J. Biblowit, President and CEO of BCRF, says: “BCRF and breast cancer research are not immune to the struggles of COVID. We know the power that our researchers play in eliminating breast cancer, and even though the world has had to pause, breast cancer hasn’t. It’s heartening to see the tremendous level of enthusiasm and innovation that Cytiva brings to the Think Pink program.”
Breast cancer affects 2.1 million women every year. BCRF is the largest private funder of breast cancer research worldwide, supporting programs on prevention, tumor biology, genetics, treatment, metastasis and survivorship.
In 2020, Cytiva’s Think Pink campaign takes place across the United States, Canada, Europe, China, Australia and New Zealand. For more information, please visit our website.